Go Saito

Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT)

Yoshihiko Sakata, Shinya Sakata, Yuko Oya et al. · European Journal of Cancer · 2021 · 81 citations

Real-world Setting, Medicine, Pathology +8

Alternative approaches for clinical clerkship during the COVID-19 pandemic: online simulated clinical practice for inpatients and outpatients—A mixed method

Hajime Kasai, Kiyoshi Shikino, Go Saito et al. · BMC Medical Education · 2021 · 54 citations · Full text

Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON)

Go Saito, Yuko Oya, Yoshihiko Taniguchi et al. · Lung Cancer · 2021 · 53 citations

Durvalumab Consolidation Therapy, Medicine, Metronomic Therapy +9

A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC

Daichi Fujimoto, Satoru Miura, Kenichi Yoshimura et al. · JTO Clinical and Research Reports · 2021 · 48 citations · Full text

Oncology, Medicine, Pembrolizumab Plus Chemotherapy +7

Association between Excessive Alcohol Use and Alcohol-Related Injuries in College Students: A Multi-Center Cross-Sectional Study in Japan

Hisashi Yoshimoto, Ayumi Takayashiki, Ryohei Goto et al. · The Tohoku Journal of Experimental Medicine · 2017 · 31 citations · Full text

Substance Use, Logistic Regression Analysis, Injury Prevention +17